Identifying new antiepileptic drugs through genomicsbased drug repurposing

Human Molecular Genetics

Volumn 26, Issue 3, 2017, Pages 527-537

  Mirza, Nasir ^a   Sills, Greame J ^a   Pirmohamed, Munir ^a   Marson, Anthony G ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 IODOTUBERCIDIN; ANDROSTENOL; ANTICONVULSIVE AGENT; ATORVASTATIN; CAMPTOTHECIN; CURCUMIN; LESTAURTINIB; MEPACRINE; QUINIDINE; RESVERATROL; SITAGLIPTIN; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ANTICONVULSANT ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG REPOSITIONING; DRUG RESISTANT EPILEPSY; DRUG TOLERABILITY; GENOMICS; HUMAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; TRANSCRIPTOMICS; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; EPILEPSY, TEMPORAL LOBE; GENETICS; HUMAN GENOME; PATHOLOGY; PROCEDURES; SEIZURES; SOFTWARE;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DRUG REPOSITIONING; EPILEPSY, TEMPORAL LOBE; GENOME, HUMAN; GENOMICS; HUMANS; MICE; SEIZURES; SOFTWARE; TRANSCRIPTOME;

EID: 85018363115     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw410     Document Type: Article

References (96)

1. Ngugi, A.K., Bottomley, C., Kleinschmidt, I., Sander, J.W. and Newton, C.R. (2010) Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia, 51, 883-890.
2. Brodie, M.J. (2010) Antiepileptic drug therapy the story so far. Seizure, 19, 650-655.
3. Shorvon, S.D. (1996) The epidemiology and treatment of chronic and refractory epilepsy. Epilepsia, 37 Suppl 2, S1-S3.
4. Loscher,W. and Brandt, C. (2010) Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol. Rev., 62, 668-700.
5. Pitkanen, A., Nehlig, A., Brooks-Kayal, A.R., Dudek, F.E., Friedman, D., Galanopoulou, A.S., Jensen, F.E., Kaminski, R.M., Kapur, J., Klitgaard, H., et al. (2013) Issues related to development of antiepileptogenic therapies. Epilepsia, 54 Suppl 4, 35-43.
6. Holmes, G.L. and Noebels, J.L. (2016) The Epilepsy Spectrum: Targeting Future Research Challenges. Cold Spring Harb. Perspect. Med., 6, pii: a028043.
7. Iorio, F., Rittman, T., Ge, H., Menden, M. and Saez-Rodriguez, J. (2013) Transcriptional data: a new gateway to drug repositioning?. Drug Discov. Today, 18, 350-357.
8. Wagner, A., Cohen, N., Kelder, T., Amit, U., Liebman, E., Steinberg, D.M., Radonjic, M. and Ruppin, E. (2015) Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia. Mol. Syst. Biol., 11, 791.
9. Sirota, M., Dudley, J.T., Kim, J., Chiang, A.P., Morgan, A.A., Sweet-Cordero, A., Sage, J. and Butte, A.J. (2011) Discovery and preclinical validation of drug indications using compendia of public gene expression data. Science Translational Medicine, 3, 96ra77.
10. Dudley, J.T., Sirota, M., Shenoy, M., Pai, R.K., Roedder, S., Chiang, A.P., Morgan, A.A., Sarwal, M.M., Pasricha, P.J. and Butte, A.J. (2011) Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci. Transl.Med., 3, 96ra76.
11. Jahchan, N.S., Dudley, J.T., Mazur, P.K., Flores, N., Yang, D., Palmerton, A., Zmoos, A.F., Vaka, D., Tran, K.Q., Zhou, M., et al. (2013) A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discovery, 3, 1364-1377.
12. Speed, D., O'Brien, T.J., Palotie, A., Shkura, K., Marson, A.G., Balding, D.J. and Johnson, M.R. (2014) Describing the genetic architecture of epilepsy through heritability analysis. Brain: A J. Neurol., 137, 2680-2689.
13. Mirza, N., Appleton, R., Burn, S., Carr, D., Crooks, D., du Plessis, D., Duncan, R., Farah, J.O., Josan, V., Miyajima, F., et al. (2015) Identifying the biological pathways underlying human focal epilepsy: from complexity to coherence to centrality. Hum. Mol. Genet., 24, 4306-4316.
14. Mirza, N., Vasieva, O., Marson, A.G. and Pirmohamed, M. (2011) Exploring the genomic basis of pharmacoresistance in epilepsy: an integrative analysis of large-scale gene expression profiling studies on brain tissue from epilepsy surgery. Hum. Mol. Genet., 20, 4381-4394.
15. Saha, L. and Chakrabarti, A. (2014) Understanding the antikindling role and its mechanism of Resveratrol in Pentylenetetrazole induced-kindling in a rat model. Pharmacol. Biochem. Behav., 120, 57-64.
16. Hansen, K.F., Sakamoto, K., Pelz, C., Impey, S. and Obrietan, K. (2014) Profiling status epilepticus-induced changes in hippocampal RNA expression using high-throughput RNA sequencing. Sci. Rep., 4, 6930.
17. Yang, H., Qin, C., Li, Y.H., Tao, L., Zhou, J., Yu, C.Y., Xu, F., Chen, Z., Zhu, F. and Chen, Y.Z. (2016) Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information. Nucleic Acids Res., 44, D1069-D1074.
18. Barton, M.E., Klein, B.D., Wolf, H.H. and White, H.S. (2001) Pharmacological characterization of the 6Hz psychomotor seizure model of partial epilepsy. Epilepsy Res., 47, 217-227.
19. Rowley, N.M. and White, H.S. (2010) Comparative anticonvulsant efficacy in the corneal kindled mouse model of partial epilepsy: Correlation with other seizure and epilepsy models. Epilepsy Res., 92, 163-169.
20. Brown, W.C., Schiffman, D.O., Swinyard, E.A. and Goodman, L.S. (1953) Comparative assay of an antiepileptic drugs by psychomotor seizure test and minimal electroshock threshold test. J. Pharmacol. Exp. Ther., 107, 273-283.
21. Loscher, W. (2011) Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure, 20, 359-368.
22. Obeid, M., Rosenberg, E.C., Klein, P.M. and Jensen, F.E. (2014) Lestaurtinib (CEP-701) attenuates "second hit" kainic acidinduced seizures following early life hypoxic seizures. Epilepsy Res., 108, 806-810.
23. Siniscalchi, A. and Mintzer, S. (2015) Statins for poststroke seizures: the first antiepileptogenic agent?. Neurology, 85, 661-662.
24. Sehar, N., Agarwal, N.B., Vohora, D. and Raisuddin, S. (2015) Atorvastatin prevents development of kindling by modulating hippocampal levels of dopamine, glutamate, and GABA in mice. Epilepsy Behav, 42, 48-53.
25. Citraro, R., Chimirri, S., Aiello, R., Gallelli, L., Trimboli, F., Britti, D., De Sarro, G. and Russo, E. (2014) Protective effects of some statins on epileptogenesis and depressive-like behavior in WAG/Rij rats, a genetic animal model of absence epilepsy. Epilepsia, 55, 1284-1291.
26. Guo, J., Li, J., Zhou, M., Qin, F., Zhang, S., Wu, B., He, L. and Zhou, D. (2015) Statin treatment reduces the risk of poststroke seizures. Neurology, 85, 701-707.
27. Kandratavicius, L., Hallak, J.E., Carlotti, C.G., Jr., Assirati, J.A., Jr. and Leite, J.P. (2014) Hippocampal expression of heat shock proteins in mesial temporal lobe epilepsy with psychiatric comorbidities and their relation to seizure outcome. Epilepsia, 55, 1834-1843.
28. Stafstrom, C.E. (2014) Epilepsy comorbidities: how can animal models help?. Advances in Exp. Med. Biol., 813, 273-281.
29. Hester, M.S. and Danzer, S.C. (2014) Hippocampal granule cell pathology in epilepsy-a possible structural basis for comorbidities of epilepsy?. Epilepsy Behav., 38, 105-116.
30. Gaitatzis, A., Sisodiya, S.M. and Sander, J.W. (2012) The somatic comorbidity of epilepsy: a weighty but often unrecognized burden. Epilepsia, 53, 1282-1293.
31. Mazarati, A. and Sankar, R. (2016) Common mechanisms underlying epileptogenesis and the comorbidities of epilepsy. Cold Spring Harb. Perspect. Med., 6, pii: a022798.
32. Uzum, G., Akgun-Dar, K. and Aksu, U. (2010) The effects of atorvastatin on memory deficit and seizure susceptibility in pentylentetrazole-kindled rats. Epilepsy Behav., 19, 284-289.
33. Choudhary, K.M., Mishra, A., Poroikov, V.V. and Goel, R.K. (2013) Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice. Eur. J. Pharmacol., 704, 33-40.
34. Ahmad, M., Abu-Taweel, G.M., Aboshaiqah, A.E. and Ajarem, J.S. (2014) The effects of quinacrine, proglumide, and pentoxifylline on seizure activity, cognitive deficit, and oxidative stress in rat lithium-pilocarpine model of status epilepticus. Oxid. Med. Cell. Longev., 2014, 630509.
35. Smith, M., Wilcox, K.S. and White, H.S. (2007) Discovery of antiepileptic drugs. Neurotherapeutics, 4, 12-17.
36. Lim, S., Choi, S.H., Shin, H., Cho, B.J., Park, H.S., Ahn, B.Y., Kang, S.M., Yoon, J.W., Jang, H.C., Kim, Y.B., et al. (2012) Effect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in rats. PloS One, 7, e35007.
37. Briand, F., Thieblemont, Q., Burcelin, R. and Sulpice, T. (2012) Sitagliptin promotes macrophage-to-faeces reverse cholesterol transport through reduced intestinal cholesterol absorption in obese insulin resistant CETP-apoB100 transgenic mice. Diabetes, Obes. Metabol., 14, 662-665.
38. Darracq, M.A., Toy, J.M., Chen, T., Mo, C. and Cantrell, F.L. (2014) A retrospective review of isolated gliptin-exposure cases reported to a state poison control system. Clin. Toxicol. (Phila), 52, 226-230.
39. Aschner, P., Kipnes, M.S., Lunceford, J.K., Sanchez, M., Mickel, C. and Williams-Herman, D.E. (2006) Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care, 29, 2632-2637.
40. Wang, Z., Fan, Y., Xu, J., Li, L., Heng, D., Han, S., Yin, J., Peng, B., Liu, W. and He, X. (2014) Transcriptome analysis of the hippocampus in novel rat model of febrile seizures. PloS One, 9, e95237.
41. Johnson, M.R., Behmoaras, J., Bottolo, L., Krishnan, M.L., Pernhorst, K., Santoscoy, P.L., Rossetti, T., Speed, D., Srivastava, P.K., Chadeau-Hyam, M., et al. (2015) Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus. Nat. Commun., 6, 6031.
42. Roncon, P., Soukupova, M., Binaschi, A., Falcicchia, C., Zucchini, S., Ferracin, M., Langley, S.R., Petretto, E., Johnson, M.R., Marucci, G., et al. (2015) MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpineinduced epilepsy-comparison with human epileptic samples. Sci. Rep., 5, 14143.
43. Loscher, W., Klitgaard, H., Twyman, R.E. and Schmidt, D. (2013) New avenues for anti-epileptic drug discovery and development. Nat. Rev. Drug Discov., 12, 757-776.
44. Eppig, J.T., Blake, J.A., Bult, C.J., Kadin, J.A. and Richardson, J.E. (2015) The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease. Nucleic Acids Res., 43, D726-D736.
45. Liu, G., Loraine, A.E., Shigeta, R., Cline, M., Cheng, J., Valmeekam, V., Sun, S., Kulp, D. and Siani-Rose, M.A. (2003) NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res., 31, 82-86.
46. Lamb, J., Crawford, E.D., Peck, D., Modell, J.W., Blat, I.C., Wrobel, M.J., Lerner, J., Brunet, J.P., Subramanian, A., Ross, K.N., et al. (2006) The Connectivity Map: using geneexpression signatures to connect small molecules, genes, and disease. Science, 313, 1929-1935.
47. Lussier, Y.A. and Chen, J.L. (2011) The emergence of genomebased drug repositioning. Sci. Transl. Med., 3, 96ps35.
48. Siavelis, J.C., Bourdakou, M.M., Athanasiadis, E.I., Spyrou, G.M. and Nikita, K.S. (2016) Bioinformatics methods in drug repurposing for Alzheimer's disease. Brief. Bioinform., 17, 322-335.
49. Traynor, K. (2014) NIOSH revamps hazardous drugs update. Am. J. Health Syst. Pharm., 71, 2099-2100.
50. Hegde, R.N., Parashuraman, S., Iorio, F., Ciciriello, F., Capuani, F., Carissimo, A., Carrella, D., Belcastro, V., Subramanian, A., Bounti, L., et al. (2015) Unravelling druggable signalling networks that control F508del-CFTR proteostasis. Elife, 4
51. Napolitano, F., Sirci, F., Carrella, D. and di Bernardo, D. (2016) Drug-set enrichment analysis: a novel tool to investigate drug mode of action. Bioinformatics, 32, 235-241.
52. Siadaty, M.S., Shu, J. and Knaus, W.A. (2007) Relemed: sentence-level search engine with relevance score for the MEDLINE database of biomedical articles. BMC Med. Inform. Decis. Mak., 7, 1.
53. El-Sahar, A.E., Safar, M.M., Zaki, H.F., Attia, A.S. and Ain-Shoka, A.A. (2015) Sitagliptin attenuates transient cerebral ischemia/reperfusion injury in diabetic rats: implication of the oxidative-inflammatory-apoptotic pathway. Life Sciences, 126, 81-86.
54. Theiss, H.D., Gross, L., Vallaster, M., David, R., Brunner, S., Brenner, C., Nathan, P., Assmann, G., Mueller-Hoecker, J., Vogeser, M., et al. (2013) Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction. Int. J. Cardiol., 168, 3359-3369.
55. Brenner, C., Krankel, N., Kuhlenthal, S., Israel, L., Remm, F., Fischer, C., Herbach, N., Speer, T., Grabmaier, U., Laskowski, A., et al. (2014) Short-term inhibition of DPP-4 enhances endothelial regeneration after acute arterial injury via enhanced recruitment of circulating progenitor cells. Int. J. Cardiol., 177, 266-275.
56. Faul, F., Erdfelder, E., Lang, A.G. and Buchner, A. (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods, 39, 175-191.
57. Etherington, L.A., Patterson, G.E., Meechan, L., Boison, D., Irving, A.J., Dale, N. and Frenguelli, B.G. (2009) Astrocytic adenosine kinase regulates basal synaptic adenosine levels and seizure activity but not activity-dependent adenosine release in the hippocampus. Neuropharmacology, 56, 429-437.
58. Zhang, G., Franklin, P.H. and Murray, T.F. (1993) Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J. Pharmacol. Exp. Ther., 264, 1415-1424.
59. Gouder, N., Scheurer, L., Fritschy, J.M. and Boison, D. (2004) Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J. Neurosci., 24, 692-701.
60. Ugarkar, B.G., DaRe, J.M., Kopcho, J.J., Browne, C.E., 3rd, Schanzer, J.M., Wiesner, J.B. and Erion, M.D. (2000) Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues. J. Med. Chem., 43, 2883-2893.
61. Wiesner, J.B., Ugarkar, B.G., Castellino, A.J., Barankiewicz, J., Dumas, D.P., Gruber, H.E., Foster, A.C. and Erion, M.D. (1999) Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy. J. Pharmacol. Exp. Ther., 289, 1669-1677.
62. Kaminski, R.M., Marini, H., Ortinski, P.I., Vicini, S. and Rogawski, M.A. (2006) The pheromone androstenol (5 alphaandrost-16-en-3 alpha-ol) is a neurosteroid positive modulator of GABAA receptors. J. Pharmacol. Exp. Ther., 317, 694-703.
63. Russo, E., Donato di Paola, E., Gareri, P., Siniscalchi, A., Labate, A., Gallelli, L., Citraro, R. and De Sarro, G. (2013) Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacol. Res., 70, 1-12.
64. Shafaroodi, H., Moezi, L., Fakhrzad, A., Hassanipour, M., Rezayat, M. and Dehpour, A.R. (2012) The involvement of nitric oxide in the anti-seizure effect of acute atorvastatin treatment in mice. Neurol. Res., 34, 847-853.
65. Lee, J.K., Won, J.S., Singh, A.K. and Singh, I. (2008) Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death. Neurosci. Lett., 440, 260-264.
66. Moazzami, K., Emamzadeh-Fard, S. and Shabani, M. (2013) Anticonvulsive effect of atorvastatin on pentylenetetrazoleinduced seizures in mice: the role of nitric oxide pathway. Fundam. Clin. Pharmacol., 27, 387-392.
67. Moezi, L., Shafaroodi, H., Hassanipour, M., Fakhrzad, A., Hassanpour, S. and Dehpour, A.R. (2012) Chronic administration of atorvastatin induced anti-convulsant effects in mice: the role of nitric oxide. Epilepsy Behav., 23, 399-404.
68. Funck, V.R., de Oliveira, C.V., Pereira, L.M., Rambo, L.M., Ribeiro, L.R., Royes, L.F., Ferreira, J., Guerra, G.P., Furian, A.F., Oliveira, M.S., et al. (2011) Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures. Epilepsia, 52, 2094-2104.
69. Piermartiri, T.C., Vandresen-Filho, S., de Araujo Herculano, B., Martins, W.C., Dal'agnolo, D., Stroeh, E., Carqueja, C.L., Boeck, C.R. and Tasca, C.I. (2009) Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake. Neurotox. Res., 16, 106-115.
70. Song, J., Parker, L., Hormozi, L. and Tanouye, M.A. (2008) DNA topoisomerase I inhibitors ameliorate seizure-like behaviors and paralysis in a Drosophila model of epilepsy. Neuroscience, 156, 722-728.
71. Orellana-Paucar, A.M., Serruys, A.S., Afrikanova, T., Maes, J., De Borggraeve, W., Alen, J., Leon-Tamariz, F., Wilches-Arizabala, I.M., Crawford, A.D., de Witte, P.A., et al. (2012) Anticonvulsant activity of bisabolene sesquiterpenoids of Curcuma longa in zebrafish and mouse seizure models. Epilepsy & Behavior, 24, 14-22.
72. Du, P., Li, X., Lin, H.J., Peng, W.F., Liu, J.Y., Ma, Y., Fan, W. and Wang, X. (2009) Curcumin inhibits amygdaloid kindled seizures in rats. Chin. Med. J., 122, 1435-1438.
73. Agarwal, N.B., Jain, S., Nagpal, D., Agarwal, N.K., Mediratta, P.K. and Sharma, K.K. (2013) Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice. Fundam. Clin. Pharmacol., 27, 169-172.
74. Bharal, N., Sahaya, K., Jain, S., Mediratta, P.K. and Sharma, K.K. (2008) Curcumin has anticonvulsant activity on increasing current electroshock seizures in mice. Phytother. Res., 22, 1660-1664.
75. Jyoti, A., Sethi, P. and Sharma, D. (2009) Curcumin protects against electrobehavioral progression of seizures in the iron-induced experimental model of epileptogenesis. Epilepsy & Behavior, 14, 300-308.
76. Gupta, Y.K., Briyal, S. and Sharma, M. (2009) Protective effect of curcumin against kainic acid induced seizures and oxidative stress in rats. Ind. J. Physiol. Pharmacol., 53, 39-46.
77. Tamaddonfard, E., Erfanparast, A., Hamzeh-Gooshchi, N. and Yousofizadeh, S. (2012) Effect of curcumin, the active constituent of turmeric, on penicillin-induced epileptiform activity in rats. Avicenna J. Phytomed., 2, 196-205.
78. Saha, L., Chakrabarti, A., Kumari, S., Bhatia, A. and Banerjee, D. (2016) Antiapoptotic and neuroprotective role of Curcumin in Pentylenetetrazole (PTZ) induced kindling model in rat. Ind. J. Exp. Biol., 54, 133-141.
79. Zhu, W., Su, J., Liu, J. and Jiang, C. (2015) The involvement of neuronal nitric oxide synthase in the anti-epileptic action of curcumin on pentylenetetrazol-kindled rats. Bio-Med. Mater. Eng., 26 Suppl 1, S841-S850.
80. Akula, K.K. and Kulkarni, S.K. (2014) Effect of curcumin against pentylenetetrazol-induced seizure threshold in mice: possible involvement of adenosine A1 receptors. Phytother. Res., 28, 714-721.
81. Mehla, J., Reeta, K.H., Gupta, P. and Gupta, Y.K. (2010) Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model. Life Sciences, 87, 596-603.
82. Noor, N.A., Aboul Ezz, H.S., Faraag, A.R. and Khadrawy, Y.A. (2012) Evaluation of the antiepileptic effect of curcumin and Nigella sativa oil in the pilocarpine model of epilepsy in comparison with valproate. Epilepsy Behav., 24, 199-206.
83. Ezz, H.S., Khadrawy, Y.A. and Noor, N.A. (2011) The neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: a comparison with valproate. Neurochem. Res., 36, 2195-2204.
84. Ahmad, M. (2013) Protective effects of curcumin against lithium-pilocarpine induced status epilepticus, cognitive dysfunction and oxidative stress in young rats. Saudi J. Biol. Sci., 20, 155-162.
85. Agarwal, N.B., Jain, S., Agarwal, N.K., Mediratta, P.K. and Sharma, K.K. (2011) Modulation of pentylenetetrazoleinduced kindling and oxidative stress by curcumin in mice. Phytomedicine, 18, 756-759.
86. Jiang, Z., Guo, M., Shi, C., Wang, H., Yao, L., Liu, L., Xie, C., Pu, S., LaChaud, G., Shen, J., et al. (2015) Protection against cognitive impairment and modification of epileptogenesis with curcumin in a post-status epilepticus model of temporal lobe epilepsy. Neuroscience, 310, 362-371.
87. Auta, J., Romeo, E., Kozikowski, A., Ma, D., Costa, E. and Guidotti, A. (1993) Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives. J. Pharmacol. Exp. Therap., 265, 649-656.
88. Romeo, E., Auta, J., Kozikowski, A.P., Ma, D., Papadopoulos, V., Puia, G., Costa, E. and Guidotti, A. (1992) 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). J. Pharmacol. Exp. Therap., 262, 971-978.
89. Tsuda, M., Suzuki, T. and Misawa, M. (1998) Subsensitivity to mitochondrial diazepam binding inhibitor receptor agonist FGIN-1-27-induced antiseizure effect in diazepamwithdrawn mice. Life Sciences, 62, PL213-PL217.
90. Steriade, M. and Stoica, E. (1960) On the anticonvulsive effect of quinidine. I. Experimental investigation of somatomotor, vegetative and bioelectrical aspects of convulsive seizures elicited by electroshocks. Epilepsia, 1, 264-274.
91. Steriade, M. and Stoica, E. (1960) On the anticonvulsive effect of quinidine. II. Experimental investigations of focal electrical after-discharge and penicillin epilepsy. Epilepsia, 1, 275-284.
92. Gupta, Y.K., Chaudhary, G., Sinha, K. and Srivastava, A.K. (2001) Protective effect of resveratrol against intracortical FeCl3-induced model of posttraumatic seizures in rats. Methods Find Exp. Clin. Pharmacol., 23, 241-244.
93. Hoda, U., Agarwal, N.B., Vohora, D., Parvez, S. and Raisuddin, S. (2016) Resveratrol suppressed seizures by attenuating IL-1beta, IL1-Ra, IL-6, and TNF-alpha in the hippocampus and cortex of kindled mice. Nutr. Neurosci., 2, 1-8.
94. Gupta, Y.K., Briyal, S. and Chaudhary, G. (2002) Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats. Pharmacol. Biochem. Behav., 71, 245-249.
95. Wu, Z., Xu, Q., Zhang, L., Kong, D., Ma, R. and Wang, L. (2009) Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem. Res., 34, 1393-1400.
96. Gupta, Y.K., Chaudhary, G. and Srivastava, A.K. (2002) Protective effect of resveratrol against pentylenetetrazoleinduced seizures and its modulation by an adenosinergic system. Pharmacology, 65, 170-174.